Research Focus

Former Employee. Molecular Pharmacology Program; Visiting Investigator

Recent additions – View all

1. A phase 3 randomized, historically-controlled clinical trial investigating the use of defibrotide in the treatment of severe veno occlusive disease Post-SCT: A novel approach to the validation of a promising new drug for the treatment of a life threatening disease

   Meeting Abstract

   Richardson, P.; Keman, N.; Tomblyn, M.; Martin, P.; Arai, S.; Brochstein, J.; Guinan, E.; Steinbach, G.; Nemecek, E.; D'Agostino, R.; more...
   Blood (2007)

   Fulltext@MSK | Save
2. Targeting the PML/RARα translocation product triggers apoptosis in promyelocytic leukemia cells

   Journal Article

   Nason-Burchenal, K.; Takle, G.; Pace, U.; Flynn, S.; Allopenna, J.; Martin, P.; George, S. T.; Goldberg, A. R.; Dmitrovsky, E.
   Oncogene (1998)

   Fulltext@MSK | Save
3. Targeting of PML/RARα is lethal to retinoic acid-resistant promyelocytic leukemia cells

   Journal Article

   Nason-Burchenal, K.; Allopenna, J.; Bègue, A.; Stéhelin, D.; Dmitrovsky, E.; Martin, P.
   Blood (1998)

   Fulltext@MSK | Save